Management of neuropathic orofacial pain

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 103, Issue SUPPL., 2007, Pages S32.e1-S32.e24

  Lewis, Michael A O ^a   Sankar, Vidya ^b   De Laat, Antoon ^c   Benoliel, Rafael ^d  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c DEPARTMENT OF IMAGING AND PATHOLOGY   (Belgium)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33947241894     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2006.10.014     Document Type: Article

References (248)

1. Merskey H., and Bogduk N. Classification of chronic pain: descriptions of chronic pain syndromes and definition of pain terms. 2nd ed. (1994), IASP Press, Seattle
2. Benoliel R., and Sharav Y. Neuropathic orofacial pain. Compend Contin Educ Dent 19 (1998) 1099-1102 1104, passim; quiz 1116
3. Okeson J.P. Orofacial pain: guidelines for assessment, classification, and management. The American Academy of Orofacial Pain (1996), Quintessence Publishing, Chicago, IL
4. Rasmussen P.V., Sindrup S.H., Jensen T.S., and Bach F.W. Symptoms and signs in patients with suspected neuropathic pain. Pain 110 (2004) 461-469
5. Olesen J., Bousser M.-G., Diener H.C., et al. The international classification of headache disorders, 2nd edition. Cephalalgia 24 suppl 1 (2004) 24-150
6. Max M.B. Clarifying the definition of neuropathic pain. Pain 96 (2002) 406-407 author reply 407-8
7. Woolf C.J. Pain: moving from symptom control toward mechanism-specific pharmacologic management. Ann Intern Med 140 (2004) 441-451
8. Woolf C.J., Bennett G.J., Doherty M., et al. Towards a mechanism-based classification of pain?. Pain 77 (1998) 227-229
9. Beniczky S., Tajti J., Timea Varga E., and Vecsei L. Evidence-based pharmacological treatment of neuropathic pain syndromes. J Neural Transm 112 (2005) 735-749
10. Wallace M.S. Diagnosis and treatment of neuropathic pain. Curr Opin Anaesthesiol 18 (2005) 548-554
11. Clark J.D. Chronic pain prevalence and analgesic prescribing in a general medical population. J Pain Symptom Manage 23 (2002) 131-137
12. Hasselstrom J., Liu-Palmgren J., and Rasjo-Wraak G. Prevalence of pain in general practice. Eur J Pain 6 (2002) 375-385
13. Koleva D., Krulichova I., Bertolini G., Caimi V., and Garattini L. Pain in primary care: an Italian survey. Eur J Public Health 15 (2005) 475-479
14. Torrance N., Smith B.H., Bennett M.I., and Lee A.J. The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain 7 (2006) 281-289
15. Hall G.C., Carroll D., Parry D., and McQuay H.J. Epidemiology and treatment of neuropathic pain: the UK primary care perspective. Pain 122 (2006) 156-162
16. McDermott A.M., Toelle T.R., Rowbotham D.J., Schaefer C.P., and Dukes E.M. The burden of neuropathic pain: results from a cross-sectional survey. Eur J Pain 10 (2006) 127-135
17. Meyer-Rosberg K., Burckhardt C.S., Huizar K., Kvarnstrom A., Nordfors L.O., and Kristofferson A. A comparison of the SF-36 and Nottingham Health Profile in patients with chronic neuropathic pain. Eur J Pain 5 (2001) 391-403
18. Meyer-Rosberg K., Kvarnstrom A., Kinnman E., Gordh T., Nordfors L.O., and Kristofferson A. Peripheral neuropathic pain-a multidimensional burden for patients. Eur J Pain 5 (2001) 379-389
19. Fried K., Bongenhielm U., Boissonade F.M., and Robinson P.P. Nerve injury-induced pain in the trigeminal system. Neuroscientist 7 (2001) 155-165
20. Sessle B.J. Neural mechanisms and pathways in craniofacial pain. Can J Neurol Sci 26 Suppl 3 (1999) S7-S11
21. Sessle B.J. Acute and chronic craniofacial pain: brainstem mechanisms of nociceptive transmission and neuroplasticity, and their clinical correlates. Crit Rev Oral Biol Med 11 (2000) 57-91
22. Sessle B.J. Recent insights into brainstem mechanisms underlying craniofacial pain. J Dent Educ 66 (2002) 108-112
23. Sessle B.J. Peripheral and central mechanisms of orofacial pain and their clinical correlates. Minerva Anestesiol 71 (2005) 117-136
24. Nurmikko T.J., and Eldridge P.R. Trigeminal neuralgia-pathophysiology, diagnosis and current treatment. Br J Anaesth 87 (2001) 117-132
25. Sato J., Saitoh T., Notani K., Fukuda H., Kaneyama K., and Segami N. Diagnostic significance of carbamazepine and trigger zones in trigeminal neuralgia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97 (2004) 18-22
26. Tyler-Kabara E.C., Kassam A.B., Horowitz M.H., et al. Predictors of outcome in surgically managed patients with typical and atypical trigeminal neuralgia: comparison of results following microvascular decompression. J Neurosurg 96 (2002) 527-531
27. Casey K.F. Role of patient history and physical examination in the diagnosis of trigeminal neuralgia. Neurosurg Focus 18 (2005) E1
28. Bowsher D. Trigeminal neuralgia: a symptomatic study of 126 successive patients with and without previous interventions. Pain Clinic 12 (2000) 93-98
29. de Siqueira S.R., Nobrega J.C., Valle L.B., Teixeira M.J., and de Siqueira J.T. Idiopathic trigeminal neuralgia: clinical aspects and dental procedures. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98 (2004) 311-315
30. Law A.S., and Lilly J.P. Trigeminal neuralgia mimicking odontogenic pain. A report of two cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 80 (1995) 96-100
31. Mitchell R.G. Pre-trigeminal neuralgia. Br Dent J 149 (1980) 167-170
32. Taha J.M., Tew Jr. J.M., and Buncher C.R. A prospective 15-year follow up of 154 consecutive patients with trigeminal neuralgia treated by percutaneous stereotactic radiofrequency thermal rhizotomy. J Neurosurg 83 (1995) 989-993
33. MacDonald B.K., Cockerell O.C., Sander J.W., and Shorvon S.D. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 123 Pt 4 (2000) 665-676
34. Katusic S., Beard C.M., Bergstralh E., and Kurland L.T. Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945-1984. Ann Neurol 27 (1990) 89-95
35. Katusic S., Williams D.B., Beard C.M., Bergstralh E.J., and Kurland L.T. Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota, 1945-1984. Neuroepidemiology 10 (1991) 276-281
36. Zakrzewska J.M. Trigeminal neuralgia. Clin Evid 9 (2003) 1490-1498
37. Love S., and Coakham H.B. Trigeminal neuralgia: pathology and pathogenesis. Brain 124 (2001) 2347-2360
38. Apfelbaum R.I. Surgery for tic douloureux. Clin Neurosurg 31 (1983) 351-368
39. Barker II F.G., Jannetta P.J., Bissonette D.J., Larkins M.V., and Jho H.D. The long-term outcome of microvascular decompression for trigeminal neuralgia. N Engl J Med 334 (1996) 1077-1083
40. Kolluri S., and Heros R.C. Microvascular decompression for trigeminal neuralgia. A five-year follow-up study. Surg Neurol 22 (1984) 235-240
41. Matsushima T., Huynh-Le P., and Miyazono M. Trigeminal neuralgia caused by venous compression. Neurosurgery 55 (2004) 334-337 discussion 338-9
42. Szapiro Jr. J., Sindou M., and Szapiro J. Prognostic factors in microvascular decompression for trigeminal neuralgia. Neurosurgery 17 (1985) 920-929
43. Baldwin N.G., Sahni K.S., Jensen M.E., Pieper D.R., Anderson R.L., and Young H.F. Association of vascular compression in trigeminal neuralgia versus other "facial pain syndromes" by magnetic resonance imaging. Surg Neurol 36 (1991) 447-452
44. Boecher-Schwarz H.G., Bruehl K., Kessel G., Guenthner M., Perneczky A., and Stoeter P. Sensitivity and specificity of MRA in the diagnosis of neurovascular compression in patients with trigeminal neuralgia. A correlation of MRA and surgical findings. Neuroradiology 40 (1998) 88-95
45. Masur H., Papke K., Bongartz G., and Vollbrecht K. The significance of three-dimensional MR-defined neurovascular compression for the pathogenesis of trigeminal neuralgia. J Neurol 242 (1995) 93-98
46. Meaney J.F., Eldridge P.R., Dunn L.T., Nixon T.E., Whitehouse G.H., and Miles J.B. Demonstration of neurovascular compression in trigeminal neuralgia with magnetic resonance imaging. Comparison with surgical findings in 52 consecutive operative cases. J Neurosurg 83 (1995) 799-805
47. Meaney J.F., Watt J.W., Eldridge P.R., Whitehouse G.H., Wells J.C., and Miles J.B. Association between trigeminal neuralgia and multiple sclerosis: role of magnetic resonance imaging. J Neurol Neurosurg Psychiatry 59 (1995) 253-259
48. Anderson V.C., Berryhill P.C., Sandquist M.A., Ciaverella D.P., Nesbit G.M., and Burchiel K.J. High-resolution three-dimensional magnetic resonance angiography and three-dimensional spoiled gradient-recalled imaging in the evaluation of neurovascular compression in patients with trigeminal neuralgia: a double-blind pilot study. Neurosurgery 58 (2006) 666-673 discussion 666-73
49. Barker II F.G., Jannetta P.J., Babu R.P., Pomonis S., Bissonette D.J., and Jho H.D. Long-term outcome after operation for trigeminal neuralgia in patients with posterior fossa tumors. J Neurosurg 84 (1996) 818-825
50. McLaughlin M.R., Jannetta P.J., Clyde B.L., Subach B.R., Comey C.H., and Resnick D.K. Microvascular decompression of cranial nerves: lessons learned after 4400 operations. J Neurosurg 90 (1999) 1-8
51. Miles J.B., Eldridge P.R., Haggett C.E., and Bowsher D. Sensory effects of microvascular decompression in trigeminal neuralgia. J Neurosurg 86 (1997) 193-196
52. Taha J.M., and Tew Jr. J.M. Comparison of surgical treatments for trigeminal neuralgia: reevaluation of radiofrequency rhizotomy. Neurosurgery 38 (1996) 865-871
53. Hamlyn P.J. Neurovascular relationships in the posterior cranial fossa, with special reference to trigeminal neuralgia. 2. Neurovascular compression of the trigeminal nerve in cadaveric controls and patients with trigeminal neuralgia: quantification and influence of method. Clin Anat 10 (1997) 380-388
54. Kuroiwa T., Matsumoto S., Kato A., et al. MR imaging of idiopathic trigeminal neuralgia: correlation with non-surgical therapy. Radiat Med 14 (1996) 235-239
55. Devor M., Govrin-Lippmann R., and Rappaport Z.H. Mechanism of trigeminal neuralgia: an ultrastructural analysis of trigeminal root specimens obtained during microvascular decompression surgery. J Neurosurg 96 (2002) 532-543
56. Rappaport Z.H., Govrin-Lippmann R., and Devor M. An electron-microscopic analysis of biopsy samples of the trigeminal root taken during microvascular decompressive surgery. Stereotact Funct Neurosurg 68 (1997) 182-186
57. Beaver D.L. Electron microscopy of the gasserian ganglion in trigeminal neuralgia. J Neurosurg 26 Suppl (1967) 138-150
58. Kerr F.W. Pathology of trigeminal neuralgia: light and electron microscopic observations. J Neurosurg 26 Suppl (1967) 151-156
59. Kerr F.W., and Miller R.H. The pathology of trigeminal neuralgia. Electron microscopic studies. Arch Neurol 15 (1966) 308-319
60. Amir R., Michaelis M., and Devor M. Membrane potential oscillations in dorsal root ganglion neurons: role in normal electrogenesis and neuropathic pain. J Neurosci 19 (1999) 8589-8596
61. Liu C.N., Michaelis M., Amir R., and Devor M. Spinal nerve injury enhances subthreshold membrane potential oscillations in DRG neurons: relation to neuropathic pain. J Neurophysiol 84 (2000) 205-215
62. Liu C.N., Wall P.D., Ben-Dor E., Michaelis M., Amir R., and Devor M. Tactile allodynia in the absence of C-fiber activation: altered firing properties of DRG neurons following spinal nerve injury. Pain 85 (2000) 503-521
63. Amir R., and Devor M. Functional cross-excitation between afferent A- and C-neurons in dorsal root ganglia. Neuroscience 95 (2000) 189-195
64. Devor M., Amir R., and Rappaport Z.H. Pathophysiology of trigeminal neuralgia: the ignition hypothesis. Clin J Pain 18 (2002) 4-13
65. Rappaport Z.H., and Devor M. Trigeminal neuralgia: the role of self-sustaining discharge in the trigeminal ganglion. Pain 56 (1994) 127-138
66. Broggi G., Ferroli P., Franzini A., et al. Operative findings and outcomes of microvascular decompression for trigeminal neuralgia in 35 patients affected by multiple sclerosis. Neurosurgery 55 (2004) 830-838 discussion 838-9
67. Hamlyn P.J. Neurovascular relationships in the posterior cranial fossa, with special reference to trigeminal neuralgia. 1. Review of the literature and development of a new method of vascular injection-filling in cadaveric controls. Clin Anat 10 (1997) 371-379
68. Dubner R., Sharav Y., Gracely R.H., and Price D.D. Idiopathic trigeminal neuralgia: sensory features and pain mechanisms. Pain 31 (1987) 23-33
69. Fromm G.H. Baclofen as an adjuvant analgesic. J Pain Symptom Manage 9 (1994) 500-509
70. Zakrzewska J.M., Chaudhry Z., Nurmikko T.J., Patton D.W., and Mullens E.L. Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain 73 (1997) 223-230
71. Solaro C., Messmer Uccelli M., Uccelli A., Leandri M., and Mancardi G.L. Low-dose gabapentin combined with either lamotrigine or carbamazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis. Eur Neurol 44 (2000) 45-48
72. Cheshire Jr. W.P. Defining the role for gabapentin in the treatment of trigeminal neuralgia: a retrospective study. J Pain 3 (2002) 137-142
73. Sindrup S.H., and Jensen T.S. Pharmacotherapy of trigeminal neuralgia. Clin J Pain 18 (2002) 22-27
74. Peiris J.B., Perera G.L., Devendra S.V., and Lionel N.D. Sodium valproate in trigeminal neuralgia. Med J Aust 2 (1980) 278
75. Zvartau-Hind M., Din M.U., Gilani A., Lisak R.P., and Khan O.A. Topiramate relieves refractory trigeminal neuralgia in MS patients. Neurology 55 (2000) 1587-1588
76. Loeser J.D. Herpes zoster and postherpetic neuralgia. Pain 25 (1986) 149-164
77. Portenoy R.K., Duma C., and Foley K.M. Acute herpetic and postherpetic neuralgia: clinical review and current management. Ann Neurol 20 (1986) 651-664
78. Steiner I. Human herpes viruses latent infection in the nervous system. Immunol Rev 152 (1996) 157-173
79. Zerboni L., Ku C.C., Jones C.D., Zehnder J.L., and Arvin A.M. Varicella-zoster virus infection of human dorsal root ganglia in vivo. Proc Natl Acad Sci U S A 102 (2005) 6490-6495
80. Goh C.L., and Khoo L. A retrospective study of the clinical presentation and outcome of herpes zoster in a tertiary dermatology outpatient referral clinic. Int J Dermatol 36 (1997) 667-672
81. Haanpaa M., Laippala P., and Nurmikko T. Pain and somatosensory dysfunction in acute herpes zoster. Clin J Pain 15 (1999) 78-84
82. Jung B.F., Johnson R.W., Griffin D.R., and Dworkin R.H. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology 62 (2004) 1545-1551
83. Ragozzino M.W., Melton III L.J., Kurland L.T., Chu C.P., and Perry H.O. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) 61 (1982) 310-316
84. Dworkin R.H., Nagasako E.M., Johnson R.W., and Griffin D.R. Acute pain in herpes zoster: the famciclovir database project. Pain 94 (2001) 113-119
85. Volpi A., Gross G., Hercogova J., and Johnson R.W. Current management of herpes zoster: the European view. Am J Clin Dermatol 6 (2005) 317-325
86. Beutner K.R., Friedman D.J., Forszpaniak C., Andersen P.L., and Wood M.J. Valaciclovir compared with aciclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 39 (1995) 1546-1553
87. Davis L.E., and King M.K. Shingles (herpes zoster) and post-herpetic neuralgia. Curr Treat Options Neurol 3 (2001) 401-411
88. Schmader K. Herpes zoster in older adults. Clin Infect Dis 32 (2001) 1481-1486
89. Wood M.J., Kay R., Dworkin R.H., Soong S.J., and Whitley R.J. Oral aciclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials. Clin Infect Dis 22 (1996) 341-347
90. Tyring S.K., Beutner K.R., Tucker B.A., Anderson W.C., and Crooks R.J. Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valaciclovir and famciclovir therapy in immunocompetent patients 50 years and older. Arch Fam Med 9 (2000) 863-869
91. Tyring S., Barbarash R.A., Nahlik J.E., et al., Collaborative Famciclovir Herpes Zoster Study Group. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 123 (1995) 89-96
92. Brown G.R. Herpes zoster: correlation of age, sex, distribution, neuralgia, and associated disorders. South Med J 69 (1976) 576-578
93. Coen P.G., Scott F., Leedham-Green M., et al. Predicting and preventing post-herpetic neuralgia: are current risk factors useful in clinical practice?. Eur J Pain 10 (2006) 695-700
94. Dworkin R.H., and Portenoy R.K. Pain and its persistence in herpes zoster. Pain 67 (1996) 241-251
95. Dworkin R.H., and Portenoy R.K. Proposed classification of herpes zoster pain. Lancet 343 (1994) 1648
96. Zacks S.I., Elliott F.A., and Langfitt T.W. Herpetic neuritis: a light and electron microscopic study. Neurology 14 (1964) 744-750
97. Watson C.P., Deck J.H., Morshead C., Van der Kooy D., and Evans R.J. Post-herpetic neuralgia: further post-mortem studies of cases with and without pain. Pain 44 (1991) 105-117
98. Nurmikko T.J., and Haanpaa M. Treatment of postherpetic neuralgia. Curr Pain Headache Rep 9 (2005) 161-167
99. Oaklander A.L., Romans K., Horasek S., Stocks A., Hauer P., and Meyer R.A. Unilateral postherpetic neuralgia is associated with bilateral sensory neuron damage. Ann Neurol 44 (1998) 789-795
100. Bowsher D. Postherpetic neuralgia and its treatment: a retrospective survey of 191 patients. J Pain Symptom Manage 12 (1996) 290-299
101. Pappagallo M., Oaklander A.L., Quatrano-Piacentini A.L., Clark M.R., and Raja S.N. Heterogenous patterns of sensory dysfunction in postherpetic neuralgia suggest multiple pathophysiologic mechanisms. Anesthesiology 92 (2000) 691-698
102. Alper B.S., and Lewis P.R. Treatment of postherpetic neuralgia: a systematic review of the literature. J Fam Pract 51 (2002) 121-128
103. Dubinsky R.M., Kabbani H., El-Chami Z., Boutwell C., and Ali H. Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 63 (2004) 959-965
104. Wareham D. Postherpetic neuralgia. Clin Evid (2004) 1182-1193
105. Watson C.P., Tyler K.L., Bickers D.R., Millikan L.E., Smith S., and Coleman E. A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Ther 15 (1993) 510-526
106. Raja S.N., Haythornthwaite J.A., Pappagallo M., et al. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 59 (2002) 1015-1021
107. Hempenstall K., Nurmikko T.J., Johnson R.W., A'Hern R.P., and Rice A.S. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med 2 (2005) e164
108. Watson C.P., and Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 50 (1998) 1837-1841
109. Wiffen P.J., McQuay H.J., Edwards J.E., and Moore R.A. Gabapentin for acute and chronic pain. Cochrane Database Syst Rev 3 (2005) CD005452
110. Frampton J.E., and Foster R.H. Pregabalin: in the treatment of postherpetic neuralgia. Drugs 65 (2005) 111-118 discussion 119-20
111. van Seventer R., Feister H.A., Young Jr. J.P., Stoker M., Versavel M., and Rigaudy L. Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial. Curr Med Res Opin 22 (2006) 375-384
112. Boureau F., Legallicier P., and Kabir-Ahmadi M. Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebo-controlled trial. Pain 104 (2003) 323-331
113. Benoliel R., Birenboim R., Regev E., and Eliav E. Neurosensory changes in the infraorbital nerve following zygomatic fractures. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 99 (2005) 657-665
114. Polycarpou N., Ng Y.L., Canavan D., Moles D.R., and Gulabivala K. Prevalence of persistent pain after endodontic treatment and factors affecting its occurrence in cases with complete radiographic healing. Int Endod J 38 (2005) 169-178
115. Macrae W.A. Chronic pain after surgery. Br J Anaesth 87 (2001) 88-98
116. Berge T.I. Incidence of chronic neuropathic pain subsequent to surgical removal of impacted third molars. Acta Odontol Scand 60 (2002) 108-112
117. Valmaseda-Castellon E., Berini-Aytes L., and Gay-Escoda C. Lingual nerve damage after third lower molar surgical extraction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90 (2000) 567-573
118. Carmichael F.A., and McGowan D.A. Incidence of nerve damage following third molar removal: a West of Scotland Oral Surgery Research Group study. Br J Oral Maxillofac Surg 30 (1992) 78-82
119. Queral-Godoy E., Valmaseda-Castellon E., Berini-Aytes L., and Gay-Escoda C. Incidence and evolution of inferior alveolar nerve lesions following lower third molar extraction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 99 (2005) 259-264
120. Robinson P.P., and Smith K.G. Lingual nerve damage during lower third molar removal: a comparison of two surgical methods. Br Dent J 180 (1996) 456-461
121. Swanson A.E. Incidence of inferior alveolar nerve injury in mandibular third molar surgery. J Can Dent Assoc 57 (1991) 327-328
122. Valmaseda-Castellon E., Berini-Aytes L., and Gay-Escoda C. Inferior alveolar nerve damage after lower third molar surgical extraction: a prospective study of 1117 surgical extractions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92 (2001) 377-383
123. Gregg J.M. Neuropathic complications of mandibular implant surgery: review and case presentations. Ann R Australas Coll Dent Surg 15 (2000) 176-180
124. Cheung L.K., and Lo J. The long-term clinical morbidity of mandibular step osteotomy. Int J Adult Orthodon Orthognath Surg 17 (2002) 283-290
125. Neal C.E., and Kiyak H.A. Patient perceptions of pain, paresthesia, and swelling after orthognathic surgery. Int J Adult Orthodon Orthognath Surg 6 (1991) 169-181
126. Walton J.N. Altered sensation associated with implants in the anterior mandible: a prospective study. J Prosthet Dent 83 (2000) 443-449
127. Vora A.R., Loescher A.R., Craig G.T., Boissonade F.M., and Robinson P.P. A light microscopical study on the structure of traumatic neuromas of the human lingual nerve. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 99 (2005) 395-403
128. Vora A.R., Loescher A.R., Boissonade F.M., and Robinson P.P. Ultrastructural characteristics of axons in traumatic neuromas of the human lingual nerve. J Orofac Pain 19 (2005) 22-33
129. Campbell R.L., Parks K.W., and Dodds R.N. Chronic facial pain associated with endodontic therapy. Oral Surg Oral Med Oral Pathol 69 (1990) 287-290
130. Marbach J.J., Hulbrock J., Hohn C., and Segal A.G. Incidence of phantom tooth pain: an atypical facial neuralgia. Oral Surg Oral Med Oral Pathol 53 (1982) 190-193
131. Lobb W.K., Zakariasen K.L., and McGrath P.J. Endodontic treatment outcomes: do patients perceive problems?. J Am Dent Assoc 127 (1996) 597-600
132. Janig W., and Baron R. Experimental approach to CRPS. Pain 108 (2004) 3-7
133. Melis M., Zawawi K., al-Badawi E., Lobo Lobo S., and Mehta N. Complex regional pain syndrome in the head and neck: a review of the literature. J Orofac Pain 16 (2002) 93-104
134. Benoliel R., Eliav E., and Tal M. No sympathetic nerve sprouting in rat trigeminal ganglion following painful and non-painful infraorbital nerve neuropathy. Neurosci Lett 297 (2001) 151-154
135. Bongenhielm U., Boissonade F.M., Westermark A., Robinson P.P., and Fried K. Sympathetic nerve sprouting fails to occur in the trigeminal ganglion after peripheral nerve injury in the rat. Pain 82 (1999) 283-288
136. Tal M., and Devor M. Ectopic discharge in injured nerves: comparison of trigeminal and somatic afferents. Brain Res 579 (1992) 148-151
137. Benoliel R., Eliav E., and Iadarola M.J. Neuropeptide Y in trigeminal ganglion following chronic constriction injury of the rat infraorbital nerve: is there correlation to somatosensory parameters?. Pain 91 (2001) 111-121
138. Julius D., and Basbaum A.I. Molecular mechanisms of nociception. Nature 413 (2001) 203-210
139. Doubell T.P., Mannion R.J., and Woolf C.J. The dorsal horn: state-dependent sensory processing, plasticity and the generation of pain. In: Wall P.D., and Melzack R. (Eds). Pain (1999), Churchill Livingstone, London, UK 165-181
140. Devor M., and Seltzer Z. Pathophysiology of damaged nerves in relation to chronic pain. In: Wall P.D., and Melzack R. (Eds). Pain (1999), Churchill Livingstone, London, UK 129-164
141. Eliav E., Herzberg U., Ruda M.A., and Bennett G.J. Neuropathic pain from an experimental neuritis of the rat sciatic nerve. Pain 83 (1999) 169-182
142. Watkins L.R., and Maier S.F. Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol Rev 82 (2002) 981-1011
143. White F.A., Bhangoo S.K., and Miller R.J. Chemokines: integrators of pain and inflammation. Nat Rev Drug Discov 4 (2005) 834-844
144. Benoliel R., Wilensky A., Tal M., and Eliav E. Application of a pro-inflammatory agent to the orbital portion of the rat infraorbital nerve induces changes indicative of ongoing trigeminal pain. Pain 99 (2002) 567-578
145. Eliav E., Benoliel R., and Tal M. Inflammation with no axonal damage of the rat saphenous nerve trunk induces ectopic discharge and mechanosensitivity in myelinated axons. Neurosci Lett 311 (2001) 49-52
146. Amir R., Kocsis J.D., and Devor M. Multiple interacting sites of ectopic spike electrogenesis in primary sensory neurons. J Neurosci 25 (2005) 2576-2585
147. Chen Y., and Devor M. Ectopic mechanosensitivity in injured sensory axons arises from the site of spontaneous electrogenesis. Eur J Pain 2 (1998) 165-178
148. Long A., Bongenhielm U., Boissonade F.M., Fried K., and Robinson P.P. Neuropeptide immunoreactivity in ligature-induced neuromas of the inferior alveolar nerve in the ferret. Brain Res 791 (1998) 263-270
149. Devor M., Govrin-Lippmann R., and Angelides K. Na+ channel immunolocalization in peripheral mammalian axons and changes following nerve injury and neuroma formation. J Neurosci 13 (1993) 1976-1992
150. Luo Z.D., Chaplan S.R., Higuera E.S., et al. Upregulation of dorsal root ganglion (alpha)2(delta) calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats. J Neurosci 21 (2001) 1868-1875
151. Waxman S.G., Dib-Hajj S., Cummins T.R., and Black J.A. Sodium channels and their genes: dynamic expression in the normal nervous system, dysregulation in disease states(1). Brain Res 886 (2000) 5-14
152. Chaplan S.R., Guo H.Q., Lee D.H., et al. Neuronal hyperpolarization-activated pacemaker channels drive neuropathic pain. J Neurosci 23 (2003) 1169-1178
153. Chen Y., Michaelis M., Janig W., and Devor M. Adrenoreceptor subtype mediating sympathetic-sensory coupling in injured sensory neurons. J Neurophysiol 76 (1996) 3721-3730
154. Shinder V., Govrin-Lippmann R., Cohen S., et al. Structural basis of sympathetic-sensory coupling in rat and human dorsal root ganglia following peripheral nerve injury. J Neurocytol 28 (1999) 743-761
155. McLachlan E.M., Janig W., Devor M., and Michaelis M. Peripheral nerve injury triggers noradrenergic sprouting within dorsal root ganglia. Nature 363 (1993) 543-546
156. Woolf C.J., and Salter M.W. Neuronal plasticity: increasing the gain in pain. Science 288 (2000) 1765-1769
157. Tandrup T., Woolf C.J., and Coggeshall R.E. Delayed loss of small dorsal root ganglion cells after transection of the rat sciatic nerve. J Comp Neurol 422 (2000) 172-180
158. Campbell J.N., Raja S.N., Meyer R.A., and Mackinnon S.E. Myelinated afferents signal the hyperalgesia associated with nerve injury. Pain 32 (1988) 89-94
159. Mannion R.J., Doubell T.P., Gill H., and Woolf C.J. Deafferentation is insufficient to induce sprouting of A-fibre central terminals in the rat dorsal horn. J Comp Neurol 393 (1998) 135-144
160. Mannion R.J., Doubell T.P., Coggeshall R.E., and Woolf C.J. Collateral sprouting of uninjured primary afferent A-fibers into the superficial dorsal horn of the adult rat spinal cord after topical capsaicin treatment to the sciatic nerve. J Neurosci 16 (1996) 5189-5195
161. Sah D.W., Ossipo M.H., and Porreca F. Neurotrophic factors as novel therapeutics for neuropathic pain. Nat Rev Drug Discov 2 (2003) 460-472
162. Moore K.A., Kohno T., Karchewski L.A., Scholz J., Baba H., and Woolf C.J. Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord. J Neurosci 22 (2002) 6724-6731
163. Porreca F., Ossipov M.H., and Gebhart G.F. Chronic pain and medullary descending facilitation. Trends Neurosci 25 (2002) 319-325
164. Watkins L.R., and Maier S.F. Glia: a novel drug discovery target for clinical pain. Nat Rev Drug Discov 2 (2003) 973-985
165. Scholz J., and Woolf C.J. Can we conquer pain?. Nat Neurosci 5 Suppl (2002) 1062-1067
166. Finnerup N.B., Otto M., McQuay H.J., Jensen T.S., and Sindrup S.H. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 118 (2005) 289-305
167. Woolf C.J., and Chong M.S. Preemptive analgesia-treating postoperative pain by preventing the establishment of central sensitization. Anesth Analg 77 (1993) 362-379
168. Woolf C.J., and Mannion R.J. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 353 (1999) 1959-1964
169. Kelly D.J., Ahmad M., and Brull S.J. Preemptive analgesia II: recent advances and current trends. Can J Anaesth 48 (2001) 1091-1101
170. Kelly D.J., Ahmad M., and Brull S.J. Preemptive analgesia I: physiological pathways and pharmacological modalities. Can J Anaesth 48 (2001) 1000-1010
171. Huse D.M., Schainbaum S., Kirsch A.J., and Tyring S. Economic evaluation of famciclovir in reducing the duration of postherpetic neuralgia. Am J Health Syst Pharm 54 (1997) 1180-1184
172. Esmann V., Geil J.P., Kroon S., et al. Prednisolone does not prevent post-herpetic neuralgia. Lancet 2 (1987) 126-129
173. Oxman M.N., Levin M.J., Johnson G.R., et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 352 (2005) 2271-2284
174. McQuay H., Carroll D., Jadad A.R., Wiffen P., and Moore A. Anticonvulsant drugs for management of pain: a systematic review. BMJ 311 (1995) 1047-1052
175. Wiffen P., Collins S., McQuay H., Carroll D., Jadad A., and Moore A. Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev 3 (2005) CD001133
176. Wiffen P.J., McQuay H.J., and Moore R.A. Carbamazepine for acute and chronic pain. Cochrane Database Syst Rev 3 (2005) CD005451
177. Campbell F.G., Graham J.G., and Zilkha K.J. Clinical trial of carbazepine (tegretol) in trigeminal neuralgia. J Neurol Neurosurg Psychiatry 29 (1966) 265-267
178. Killian J.M., and Fromm G.H. Carbamazepine in the treatment of neuralgia. Use of side effects. Arch Neurol 19 (1968) 129-136
179. Nicol B., Regine W.F., Courtney C., Meigooni A., Sanders M., and Young B. Gamma knife radiosurgery using 90 Gy for trigeminal neuralgia. J Neurosurg 93 Suppl 3 (2000) 152-154
180. Taylor J.C., Brauer S., and Espir M.L. Long-term treatment of trigeminal neuralgia with carbamazepine. Postgrad Med J 57 (1981) 16-18
181. Sist T., Filadora V., Miner M., and Lema M. Gabapentin for idiopathic trigeminal neuralgia: report of two cases. Neurology 48 (1997) 1467
182. Khan O.A. Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients. Neurology 51 (1998) 611-614
183. Solaro C., Lunardi G.L., Capello E., et al. An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients. Neurology 51 (1998) 609-611
184. Eisenberg E., Shifrin A., and Krivoy N. Lamotrigine for neuropathic pain. Expert Rev Neurother 5 (2005) 729-735
185. Zakrzewska J.M., and Patsalos P.N. Long-term cohort study comparing medical (oxcarbazepine) and surgical management of intractable trigeminal neuralgia. Pain 95 (2002) 259-266
186. Gilron I., Booher S.L., Rowan J.S., and Max M.B. Topiramate in trigeminal neuralgia: a randomized, placebo-controlled multiple crossover pilot study. Clin Neuropharmacol 24 (2001) 109-112
187. Solaro C., Uccelli M.M., Brichetto G., Gaspperini C., and Mancardi G. Topiramate relieves idiopathic and symptomatic trigeminal neuralgia. J Pain Symptom Manage 21 (2001) 367-368
188. Saarto T., and Wiffen P.J. Antidepressants for neuropathic pain. Cochrane Database Syst Rev 3 (2005) CD005454
189. Sindrup S.H., and Jensen T.S. Antidepressants in the treatment of neuropathic pain. In: Hanson P.T., Fields H.L., Hill R.G., and Marchettini P. (Eds). Neuropathic pain: pathophysiology and treatment 21 vol. (2001), IASP Press, Seattle (WA) 169-183
190. Forssell H., Tasmuth T., Tenovuo O., Hampf G., and Kalso E. Venlafaxine in the treatment of atypical facial pain: a randomized controlled trial. J Orofac Pain 18 (2004) 131-137
191. Goldstein D.J., Lu Y., Detke M.J., Lee T.C., and Iyengar S. Duloxetine vs placebo in patients with painful diabetic neuropathy. Pain 116 (2005) 109-118
192. Raskin J., Pritchett Y.L., Wang F., et al. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med 6 (2005) 346-356
193. Graff-Radford S.B., Shaw L.R., and Naliboff B.N. Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia. Clin J Pain 16 (2000) 188-192
194. Zuniga R.E., Schlicht C.R., and Abram S.E. Intrathecal baclofen is analgesic in patients with chronic pain. Anesthesiology 92 (2000) 876-880
195. Fromm G.H., Terrence C.F., and Chattha A.S. Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up. Ann Neurol 15 (1984) 240-244
196. Gilron I., Booher S.L., Rowan M.S., Smoller M.S., and Max M.B. A randomized, controlled trial of high-dose dextromethorphan in facial neuralgias. Neurology 55 (2000) 964-971
197. Sang C.N., Booher S., Gilron I., Parada S., and Max M.B. Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials. Anesthesiology 96 (2002) 1053-1061
198. Nelson K.A., Park K.M., Robinovitz E., Tsigos C., and Max M.B. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology 48 (1997) 1212-1218
199. Lechin F., van der Dijs B., Lechin M.E., et al. Pimozide therapy for trigeminal neuralgia. Arch Neurol 46 (1989) 960-963
200. Vilming S.T., Lyberg T., and Lataste X. Tizanidine in the management of trigeminal neuralgia. Cephalalgia 6 (1986) 181-182
201. Fromm G.H., Aumentado D., and Terrence C.F. A clinical and experimental investigation of the effects of tizanidine in trigeminal neuralgia. Pain 53 (1993) 265-271
202. Lindstrom P., and Lindblom U. The analgesic effect of tocainide in trigeminal neuralgia. Pain 28 (1987) 45-50
203. Dellemijn P. Are opioids effective in relieving neuropathic pain?. Pain 80 (1999) 453-462
204. Eisenberg E., McNicol E.D., and Carr D.B. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials. JAMA 293 (2005) 3043-3052
205. Rabben T., Skjelbred P., and Oye I. Prolonged analgesic effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain. J Pharmacol Exp Ther 289 (1999) 1060-1066
206. Duhmke R.M., Cornblath D.D., and Hollingshead J.R. Tramadol for neuropathic pain. Cochrane Database Syst Rev 2 (2004) CD003726
207. Gilron I., Bailey J.M., Tu D., Holden R.R., Weaver D.F., and Houlden R.L. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 352 (2005) 1324-1334
208. Simpson D.A. Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy. J Clin Neuromusc Disease 3 (2001) 53-62
209. Sawynok J. Topical analgesics in neuropathic pain. Curr Pharm Des 11 (2005) 2995-3004
210. Padilla M., Clark G.T., and Merrill R.L. Topical medications for orofacial neuropathic pain: a review. J Am Dent Assoc 131 (2000) 184-195
211. Lynch M.E., Clark A.J., and Sawynok J. A pilot study examining topical amitriptyline, ketamine, and a combination of both in the treatment of neuropathic pain. Clin J Pain 19 (2003) 323-328
212. Lynch M.E., Clark A.J., Sawynok J., and Sullivan M.J. Topical amitriptyline and ketamine in neuropathic pain syndromes: an open-label study. J Pain 6 (2005) 644-649
213. McCleane G. Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study. Br J Clin Pharmacol 49 (2000) 574-579
214. De Benedittis G., and Lorenzetti A. Topical aspirin/diethyl ether mixture versus indomethacin and diclofenac/diethyl ether mixtures for acute herpetic neuralgia and postherpetic neuralgia: a double-blind crossover placebo-controlled study. Pain 65 (1996) 45-51
215. Epstein J.B., and Marcoe J.H. Topical application of capsaicin for treatment of oral neuropathic pain and trigeminal neuralgia. Oral Surg Oral Med Oral Pathol 77 (1994) 135-140
216. Canavan D., Graff-Radford S.B., and Gratt B.M. Traumatic dysesthesia of the trigeminal nerve. J Orofac Pain 8 (1994) 391-396
217. Davies P.S., and Galer B.S. Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia. Drugs 64 (2004) 937-947
218. Kondziolka D., Lemley T., Kestle J.R., Lunsford L.D., Fromm G.H., and Jannetta P.J. The effect of single-application topical ophthalmic anesthesia in patients with trigeminal neuralgia. A randomized double-blind placebo-controlled trial. J Neurosurg 80 (1994) 993-997
219. Stajcic Z., Juniper R.P., and Todorovic L. Peripheral streptomycin/lidocaine injections versus lidocaine alone in the treatment of idiopathic trigeminal neuralgia. A double blind controlled trial. J Craniomaxillofac Surg 18 (1990) 243-246
220. Bittar G.T., and Graff-Radford S.B. The effects of streptomycin/lidocaine block on trigeminal neuralgia: a double blind crossover placebo controlled study. Headache 33 (1993) 155-160
221. Carroll D., Moore R.A., McQuay H.J., Fairman F., Tramer M., and Leijon G. Transcutaneous electrical nerve stimulation (TENS) for chronic pain. Cochrane Database Syst Rev 3 (2001) CD003222
222. Zhang Z. Observation on therapeutic effects of blood-letting puncture with cupping in acute trigeminal neuralgia. J Tradit Chin Med 17 (1997) 272-274
223. Hansen P.E., and Hansen J.H. Acupuncture treatment of chronic facial pain-a controlled cross-over trial. Headache 23 (1983) 66-69
224. Lu D.P., Lu G.P., and Kleinman L. Acupuncture and clinical hypnosis for facial and head and neck pain: a single crossover comparison. Am J Clin Hypn 44 (2001) 141-148
225. Myers C.D., White B.A., and Heft M.W. A review of complementary and alternative medicine use for treating chronic facial pain. J Am Dent Assoc 133 (2002) 1189-1196 quiz 1259-60
226. Seltzer S., Dewart D., Pollack R.L., and Jackson E. The effects of dietary tryptophan on chronic maxillofacial pain and experimental pain tolerance. J Psychiatr Res 17 (1982) 181-186
227. Hansen H.J., and Thoroe U. Low power laser biostimulation of chronic oro-facial pain. A double-blind placebo controlled cross-over study in 40 patients. Pain 43 (1990) 169-179
228. Marbach J.J., and Wallenstein S.L. Analgesic, mood, and hemodynamic effects of intranasal cocaine and lidocaine in chronic facial pain of deafferentation and myofascial origin. J Pain Symptom Manage 3 (1988) 73-79
229. Eide P.K., Rabben T., Skjelbred P., and Stubhaug A. The effect of peripheral glycerol on trigeminal neuropathic pain examined by quantitative assessment of abnormal pain and sensory perception. Acta Neurochir (Wien) 140 (1998) 1271-1277
230. Ong K.S., and Keng S.B. Evaluation of surgical procedures for trigeminal neuralgia. Anesth Prog 50 (2003) 181-188
231. Broggi G., Ferroli P., Franzini A., Servello D., and Dones I. Microvascular decompression for trigeminal neuralgia: comments on a series of 250 cases, including 10 patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 68 (2000) 59-64
232. Pollock B.E., and Ecker R.D. A prospective cost-effectiveness study of trigeminal neuralgia surgery. Clin J Pain 21 (2005) 317-322
233. Zakrzewska J.M., and Lopez B.C. Quality of reporting in evaluations of surgical treatment of trigeminal neuralgia: recommendations for future reports. Neurosurgery 53 (2003) 110-120 discussion 120-2
234. Lopez B.C., Hamlyn P.J., and Zakrzewska J.M. Systematic review of ablative neurosurgical techniques for the treatment of trigeminal neuralgia. Neurosurgery 54 (2004) 973-982 discussion 982-3
235. Peters G., and Nurmikko T.J. Peripheral and gasserian ganglion-level procedures for the treatment of trigeminal neuralgia. Clin J Pain 18 (2002) 28-34
236. Pradel W., Hlawitschka M., Eckelt U., Herzog R., and Koch K. Cryosurgical treatment of genuine trigeminal neuralgia. Br J Oral Maxillofac Surg 40 (2002) 244-247
237. Zakrzewska J.M. Cryotherapy for trigeminal neuralgia: a 10-year audit. Br J Oral Maxillofac Surg 29 (1991) 1-4
238. Fardy M.J., Zakrzewska J.M., and Patton D.W. Peripheral surgical techniques for the management of trigeminal neuralgia-alcohol and glycerol injections. Acta Neurochir (Wien) 129 (1994) 181-184 discussion 185
239. Erdem E., and Alkan A. Peripheral glycerol injections in the treatment of idiopathic trigeminal neuralgia: retrospective analysis of 157 cases. J Oral Maxillofac Surg 59 (2001) 1176-1180
240. Burchiel K.J., Clarke H., Haglund M., and Loeser J.D. Long-term efficacy of microvascular decompression in trigeminal neuralgia. J Neurosurg 69 (1988) 35-38
241. Kalkanis S.N., Eskandar E.N., Carter B.S., and Barker II F.G. Microvascular decompression surgery in the United States, 1996 to 2000: mortality rates, morbidity rates, and the effects of hospital and surgeon volumes. Neurosurgery 52 (2003) 1251-1261 discussion 1261-2
242. Zakrzewska J.M., Lopez B.C., Kim S.E., and Coakham H.B. Patient reports of satisfaction after microvascular decompression and partial sensory rhizotomy for trigeminal neuralgia. Neurosurgery 56 (2005) 1304-1311 discussion 1311-2
243. Jawahar A., Wadhwa R., Berk C., et al. Assessment of pain control, quality of life, and predictors of success after gamma knife surgery for the treatment of trigeminal neuralgia. Neurosurg Focus 18 (2005) E8
244. Maesawa S., Salame C., Flickinger J.C., Pirris S., Kondziolka D., and Lunsford L.D. Clinical outcomes after stereotactic radiosurgery for idiopathic trigeminal neuralgia. J Neurosurg 94 (2001) 14-20
245. Young R.F., Vermeulen S.S., Grimm P., Blasko J., and Posewitz A. Gamma knife radiosurgery for treatment of trigeminal neuralgia: idiopathic and tumor related. Neurology 48 (1997) 608-614
246. Young R.F., Vermeulen S., and Posewitz A. Gamma knife radiosurgery for the treatment of trigeminal neuralgia. Stereotact Funct Neurosurg 70 Suppl 1 (1998) 192-199
247. Henson C.F., Goldman H.W., Rosenwasser R.H., et al. Glycerol rhizotomy versus gamma knife radiosurgery for the treatment of trigeminal neuralgia: an analysis of patients treated at one institution. Int J Radiat Oncol Biol Phys 63 (2005) 82-90
248. Flickinger J.C., Pollock B.E., Kondziolka D., et al. Does increased nerve length within the treatment volume improve trigeminal neuralgia radiosurgery?. A prospective double-blind, randomized study. Int J Radiat Oncol Biol Phys 51 (2001) 449-454